Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ad-hoc News: Steyr Motors AG (EQS) +++ STEYR Aktie +3,49%

Foren & Soziale Netzwerke zur GSK ADR Aktie

 >GSK ADR Aktienkurs 
48.6 EUR    +6.1%    (TradegateBSX)
Ask: 47.4 EUR / 109 Stück
Bid: 46.8 EUR / 110 Stück
Tagesumsatz: 200 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
GSK ADR Aktie über LYNX handeln
>GSK ADR Performance
1 Woche: +1,6%
1 Monat: +0,7%
3 Monate: -1,5%
6 Monate: +8,0%
1 Jahr: +41,9%
laufendes Jahr: +9,6%
>GSK ADR Aktie
Name:  GSK PLC SP. ADR/2 NEW
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US37733W2044 / A3DMHS
Symbol/ Ticker:  GS70 (Frankfurt) / GSK (NYSE)
Kürzel:  FRA:GS70, ETR:GS70, GS70:GR, NYSE:GSK
Index:  -
Webseite:  https://www.gsk.com/
Profil:  GSK plc Sponsored ADR represents shares in GSK plc, a global healthcare company headquartered in Middlesex, United Kingdom, and founded in 1715. The company focuses on the research, development, and manufacture of pharmaceutical medicines, vaccines, ..
>Volltext..
Marktkapitalisierung:  90022.23 Mio. EUR
Unternehmenswert:  107629.41 Mio. EUR
Umsatz:  38630.62 Mio. EUR
EBITDA:  13196.44 Mio. EUR
Nettogewinn:  6883.46 Mio. EUR
Gewinn je Aktie:  3.41 EUR
Schulden:  22098.55 Mio. EUR
Liquide Mittel:  3991.56 Mio. EUR
Operativer Cashflow:  8550.14 Mio. EUR
Bargeldquote:  0.15
Umsatzwachstum:  9.19%
Gewinnwachstum:  96.65%
Dividende je Aktie:  1.54 EUR
Dividendenrendite:  3.44%
Dividendenschätzung:  3.44%
Div. Historie:  15.05.26 - 0.39606258€
20.02.26 - 0.412035€
>weitere anzeigen...
Insiderhandel -
Suchwörter:  GSK ADR, GSK, GLAXOSMITHKLINE, GLAXO
Letzte Datenerhebung:  28.07.26
>GSK ADR Kennzahlen
Aktien/ Unternehmen:
Aktien: 2002.8 Mio. St.
Frei handelbar: 99.99%
Rückkaufquote: 1.89%
Mitarbeiter: 66841
Umsatz/Mitarb.: 0.57 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 12.95%
Bewertung:
KGV: 13.43
KGV lG: 10.74
KUV: 2.35
KBV: 4.38
PEG-Ratio: 0.13
EV/EBITDA: 8.16
Rentabilität:
Bruttomarge: 72.81%
Gewinnmarge: 17.82%
Operative Marge: 24.55%
Managementeffizenz:
Gesamtkaprendite: 9.71%
Eigenkaprendite: 37.44%
 >GSK ADR Anleihen 
>GSK ADR Peer Group
Gesundheit, AIDS/ HIV- Behandlung, Infektionskrankheiten/ Impfstoffentwicklung/ Antibiotika, mRNA- & RNA- Therapien/ Forschung
 
20.07.26 - 01:51
GS: Institutional Flow BULLISH (TradingView)
 
Chart: Goldman Sachs at the $1050 strike on the daily. This one ran to a double and round-tripped back to flat, so the level to watch is whether it can reclaim the highs from earlier in the trade or keeps ranging. The setup: DarkFlow flagged institutional call flow in Goldman on July 6, positioned at the $1050 line into late August. The read leaned on a strong capital-markets and trading-revenue backdrop for the big investment banks, with the flow footprint building on a chart that still had room. A financials leader catching real accumulation while rates and market activity stayed constructive was the kind of alignment the system takes. Trade structure: the vehicle was the GS $1050 call dated August 21, flagged near $57.08. Single leg, no spread. Same rule as always: if the contract trades to half of entry, it stops there. Rode to expiry, or stopped at half. What played out: this is an honest one. The contract ran to a peak around +109%, a clean double at its best, and has since round-tripped almost exact
17.07.26 - 15:48
GS Long — Analyst upgrades and bullish CEO commentary give GS th (TradingView)
 
GS is pulling back into a neutral 4h structure with aligned swings and modest extension, sitting well below resistance; the cluster of fresh analyst upgrades and bullish CEO commentary on the economy supplies the catalyst that aligns with the LONG side and improves the odds of a bounce toward the measured target. ? Entry: 1062.80 ? Stop: 1028.70 ? Target: 1154.00 ⚖️ R:R: 2.67
20.03.26 - 16:15
Goldman Sachs: Downtrend Over? (TradingView)
 
Goldman Sachs' stock initially continued to sell off before staging a modest rebound. Although we still see more room to the downside in the primary scenario, the intended target may already have been reached. After the expected low, the stock should begin to recover and move back closer to the resistance at $1,051. After that, the broader correction should conclude on the downside. Alternatively, the upcoming rebound could already be part of the final phase of the broader impulse wave, which would carry the stock directly above the resistance at $1,051 (probability: 34%).
20.02.26 - 19:18
Barclays_PLC: sell GSK plc ADR (Sharewise)
 
Kursziel: -
14.01.26 - 18:18
Morgan_Stanley: sell GSK plc ADR (Sharewise)
 
Kursziel: -
06.01.26 - 18:03
Barclays_PLC: sell GSK plc ADR (Sharewise)
 
Kursziel: -
03.08.25 - 15:03
StockNews_com: buy GSK plc ADR (Sharewise)
 
Kursziel: -
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Respekt vor den Fakten. Gefühl für das Wichtige. Kraft zur Unabhängigkeit. - Nomen Nescio
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!